Literature DB >> 7408743

Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements.

M T Clandinin, J E Chappell, S Leong, T Heim, P R Swyer, G W Chance.   

Abstract

Total fatty acid content of infant brain was determined to assess minimal fatty acid requirements for synthesis of structural lipids in brain tissue during the first 13 weeks of life. Fatty acid accretion rates were determined by regression analysis of tissue fat components at varying postnatal ages. Quantitative fatty acid analysis indicated that postnatal accretion of long-chain polyenoic fatty acids in cerebellum, frontal and occipital brain lobes initially appeared to lag behind the rate of increase in brain weight and brain fat content. After a 4-week period total long-chain fatty acids increased at a rate similar to the increase in brain weight. Accretion of individual fatty acids in cerebellum also reflected changes in tissue total fatty acid content. These developmental changes in fatty acid components of whole brain and cerebellum are quantitatively relevant to estimation of the minimal extrauterine fatty acid requirements of the human neonate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7408743     DOI: 10.1016/0378-3782(80)90016-x

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  68 in total

Review 1.  Brain development and assessing the supply of polyunsaturated fatty acid.

Authors:  M T Clandinin
Journal:  Lipids       Date:  1999-02       Impact factor: 1.880

Review 2.  Nutrition and neurodevelopment in children: focus on NUTRIMENTHE project.

Authors:  Tania Anjos; Signe Altmäe; Pauline Emmett; Henning Tiemeier; Ricardo Closa-Monasterolo; Verónica Luque; Sheila Wiseman; Miguel Pérez-García; Eva Lattka; Hans Demmelmair; Bernadette Egan; Niels Straub; Hania Szajewska; Jayne Evans; Claire Horton; Tomas Paus; Elizabeth Isaacs; Jan Willem van Klinken; Berthold Koletzko; Cristina Campoy
Journal:  Eur J Nutr       Date:  2013-07-25       Impact factor: 5.614

3.  Randomized controlled trial of maternal omega-3 long-chain PUFA supplementation during pregnancy and early childhood development of attention, working memory, and inhibitory control.

Authors:  Jacqueline F Gould; Maria Makrides; John Colombo; Lisa G Smithers
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

Review 4.  Lipid status and fatty acid metabolism in phenylketonuria.

Authors:  M Giovannini; G Biasucci; C Agostoni; D Luotti; E Riva
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Phospholipid molecular species composition of developing fetal guinea pig brain.

Authors:  G C Burdge; A D Postle
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

6.  Low docosahexaenoic acid status is associated with reduced indices in cortical integrity in the anterior cingulate of healthy male children: a 1H MRS Study.

Authors:  Robert K McNamara; Ronald Jandacek; Patrick Tso; Wade Weber; Wen-Jang Chu; Stephen M Strakowski; Caleb M Adler; Melissa P Delbello
Journal:  Nutr Neurosci       Date:  2013-07       Impact factor: 4.994

7.  High-DHA eggs: feasibility as a means to enhance circulating DHA in mother and infant.

Authors:  Cornelius M Smuts; Emily Borod; Jeanette M Peeples; Susan E Carlson
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

8.  Synthesis of chain elongation-desaturation products of linoleic acid by liver and brain microsomes during development of the pig.

Authors:  M T Clandinin; K Wong; R R Hacker
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

9.  Biochemical effects of dietary linoleic/alpha-linolenic acid ratio in term infants.

Authors:  C L Jensen; H Chen; J K Fraley; R E Anderson; W C Heird
Journal:  Lipids       Date:  1996-01       Impact factor: 1.880

10.  Is dietary docosahexaenoic acid essential for term infants?

Authors:  M Makrides; M A Neumann; R A Gibson
Journal:  Lipids       Date:  1996-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.